A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogramXiaomei Zhang, Mingfeng Zhao, Rui Sun et al.|Cancer Immunology Immunotherapy|2024Cited by 7
A CAR-T response prediction model for r/r B-NHL patients based on a T-cell subset nomogramXiaomei Zhang, Mingfeng Zhao, Rui Sun et al.|Research Square|2023Cited by 0
Infectious Complications Distribution Following CLL1 CAR-T Cell Therapy for Acute Myeloid LeukemiaJianmei Xu, Mingfeng Zhao, Huan Zhang et al.|Research Square|2024Cited by 0
Correction: Infectious complications distribution following CLL1 CAR-T cell therapy for acute myeloid leukemiaJianmei Xu, Mingfeng Zhao, Huan Zhang et al.|Cancer Immunology Immunotherapy|2025Cited by 0
A novel fourth generation of CAR-T cells: CD19 CAR-T cells engineered to express membrane-bound interleukin-15 and CXCR5 for the treatment of lymphomaXinping Cao, Jile Liu, Mohan Zhao et al.|Clinical and Experimental Medicine|2025Cited by 0